Pular para o conteúdo principal
Início

Dedicated to discovery

  • Sobre a ELGA
    • Sobre a ELGA
    • Carreiras
    • Eventos
  • Apoio
    • Planeamento laboratorial
  • Contacto
  • EN
  • DE
  • ES
  • FR
  • IT
  • EN-US
Início
  • Produtos
    • PURELAB
      • PURELAB® Dispenser
      • PURELAB® Flex
      • PURELAB® Quest
      • PURELAB® Pharma Compliance
      • PURELAB® Chorus 1 Complete
      • PURELAB® Chorus 1
      • PURELAB® Chorus 2
      • PURELAB® Chorus 3
      • PURELAB® Chorus 2 +
    • CENTRA
      • CENTRA® R60/120
      • CENTRA® R200
      • CENTRA® RDS
    • MEDICA
      • MEDICA® 150
      • MEDICA® 7/15
      • MEDICA® BIOX 2024
      • MEDICA® Pro-R & Pro-RE
      • MEDICA® R200
      • MEDICA® EDI 15/30
      • MEDICA® Pro-LPS
      • MEDICA® Pro EDI 60/120
      • MEDICA® BIOX
      • Hubgrade
    • BIOPURE
      • BIOPURE® 300/600
    • PURENERGY® 30
    • Gama completa dos produtos ELGA
  • Aplicações
    • Análise microbiológica
    • Bioquímica Clínica
    • Cromatografia gasosa
    • Cromatografia líquida
      • High Performance Liquid Chromatography
    • Culturas de célula
    • Eletroquímica
    • Espectrofotometria
    • Espectrometria de massa
    • Espectroscopia Atómica
    • Genética
    • High Performance Liquid Chromatography (HPLC)
    • Imunoquímica
    • Requisitos de água para laboratório em geral
  • Tecnologias
    • Carbono ativado
    • Eletrodeionização (EDI)
    • Filtração
    • Osmose Reversa
    • PureSure
    • Troca iónica
    • Ultravioleta
  • Impurezas na água
    • Compostos biológicos
    • Compostos inorgânicos
    • Gases dissolvidos
    • Microrganismos e bactérias
    • Partículas
  • Conhecimento
    • BROSCHÜREN
    • Blogue
    • Estudos de caso
    • Água ultrapura
    • Guias e Livros brancos
  • Where to buy
  • Contacto
Home
  • Contacto
  • Produtos
    • PURELAB
      • PURELAB® Dispenser
      • PURELAB® Flex
      • PURELAB® Quest
      • PURELAB® Pharma Compliance
      • PURELAB® Chorus 1 Complete
      • PURELAB® Chorus 1
      • PURELAB® Chorus 2
      • PURELAB® Chorus 3
      • PURELAB® Chorus 2 +
    • CENTRA
      • CENTRA® R60/120
      • CENTRA® R200
      • CENTRA® RDS
    • MEDICA
      • MEDICA® 150
      • MEDICA® 7/15
      • MEDICA® BIOX 2024
      • MEDICA® Pro-R & Pro-RE
      • MEDICA® R200
      • MEDICA® EDI 15/30
      • MEDICA® Pro-LPS
      • MEDICA® Pro EDI 60/120
      • MEDICA® BIOX
      • Hubgrade
    • BIOPURE
      • BIOPURE® 300/600
    • PURENERGY® 30
    • Gama completa dos produtos ELGA
  • Aplicações
    • Análise microbiológica
    • Bioquímica Clínica
    • Cromatografia gasosa
    • Cromatografia líquida
      • High Performance Liquid Chromatography
    • Culturas de célula
    • Eletroquímica
    • Espectrofotometria
    • Espectrometria de massa
    • Espectroscopia Atómica
    • Genética
    • High Performance Liquid Chromatography (HPLC)
    • Imunoquímica
    • Requisitos de água para laboratório em geral
  • Tecnologias
    • Carbono ativado
    • Eletrodeionização (EDI)
    • Filtração
    • Osmose Reversa
    • PureSure
    • Troca iónica
    • Ultravioleta
  • Impurezas na água
    • Compostos biológicos
    • Compostos inorgânicos
    • Gases dissolvidos
    • Microrganismos e bactérias
    • Partículas
  • Conhecimento
    • BROSCHÜREN
    • Blogue
    • Estudos de caso
    • Água ultrapura
    • Guias e Livros brancos
  • Where to buy
  • Contacto
  • Sobre a ELGA
    • Sobre a ELGA
    • Carreiras
    • Eventos
  • Apoio
    • Planeamento laboratorial
  • Contacto
  • EN
  • DE
  • ES
  • FR
  • IT
  • EN-US
  • Política de privacidade
  • Termos e condições
  • Conformidade legal global
  • Patentes
  • Trademarks
  • Impressum
  • The Ubiquitous Presence of PFAS in the Environment
Environment & Sustainability

The Ubiquitous Presence of PFAS in the Environment

21 mar 2022
- by ELGA Editorial Team

The Ubiquitous Presence of PFAS in the EnvironmentI have written previously about the environmental issues of the widely used per- and polyfluoroalkyl substances (PFAS).  These have led to restrictions and gradual phasing-out of specific analogues, e.g., perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) (1). Currently, PFAS are detected in trace concentrations worldwide in biological and environmental matrices, even at remote and pristine locations (2). Rapid, analytical methods are required which take into account matrix effects, such as those due to protein and phospholipid content of samples, and minimise background PFAS contamination from laboratory materials and analytical instruments during sampling and instrumental analysis.

I have written previously about the environmental issues of the widely used per- and polyfluoroalkyl substances (PFAS). These have led to restrictions and gradual phasing-out of specific analogues, e.g., perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) (1). Currently, PFAS are detected in trace concentrations worldwide biological and environmental matrices, even at remote and pristine locations (2). Rapid, analytical methods are required which take into account matrix effects, such as those due to protein and phospholipid content of samples, and minimise background PFAS contamination from laboratory materials and analytical instruments during sampling and instrumental anlaysis.

 

 

Trimmel and co-workers(3)  extended the use of the hybrid solid phase extraction (HybridSPE®)  technique from liquid biological media, such as plasma and serum, to a tissue matrix. A rapid HybridSPE® protocol designed for ultra-performance liquid chromatography–electrospray ionization tandem mass spectrometry (UPLC–ESI–MS/MS) analysis was developed for the determination of 15 per- and polyfluoroalkyl substances (PFAS) in liver tissue from harbour porpoises (Phocoena phocoena).

 

Toxics 09 00183 g001 550

Figure 1. Sample preparation workflow.

Liver samples were collected from 20 harbour porpoises by-caught along the Norwegian coast and prepared as shown. The extracts were collected and transferred directly for UPLC®–MS/MS analysis. For the method development and validation, matrix standards were prepared from harbour porpoise liver. The chromatographic separation was carried out using an UPLC system coupled to a triple quadrupole mass analyser with a ZSpray ESI ion source. The LC column was a C18 (30 × 2.1 mm, 1.3 µm)  at 30 °C using a gradient elution program with 2 mM ammonium acetate in water (A) and ΜeOH (B) as binary mobile phase with a flow rate of 0.25 mL/min. The gradient elution started at 90% A, held for 0.2 min, decreased to 0% within 2.8 min (minute 3.0), held for 0.5 min (minute 3.5), and reverted to 90% at the minute 3.6, which was held for 0.4 min, for a total run time of 4.0 min. Ultra-pure water from an ELGA LabWater system was used throughout.

The method demonstrated acceptable absolute recoveries (%) ranging from 44.4 to 89.4 %. The inter-day method precision ranged from 2.15 to 15.4%, and the method limits of detection (LODs) ranged from 0.003 to 0.30 ng/g wet weight (w.w.).

The highest detection rates were found for PFOS (perfluorooctane sulfonate) and PFOSA (perfluorooctanesulfonamide) with 100%, followed by PFDA ( perfluoro-n-decanoic acid) and PFUnA (perfluoro-n-undecanoic acid) (with 95%, and PFNA (perfluoro-n-nonanoic acid) with 90%. The median concentrations for the most detected target analytes in the liver were: PFOS (60.1 ng/g w.w.)

Why Choose ELGA LabWater?

This work on the ultra-trace determination of PFAS in dolphin livers is yet another example of the highly successful use of ultra-pure water from an ELGA LabWater stand-alone water purification system for the development of new analytical methods for environmental analysis. ELGA’s proven track record in this area speaks for itself.

 

References

  1. EU Comission 2020/784 Commission Delegated Regulation (EU) 2020/784 of 8 April 2020 Amending Annex I to Regulation (EU) 2019/1021 of the European Parliament and of the Council as Regards the Listing of Perfluorooctanoic Acid (PFOA), Its Salts and PFOA-Related Compounds. 2020. Available online: https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:32020R0784&from=EN 
  2. Joerss, H.; Xie, Z.; Wagner, C.C.; Von Appen, W.-J.; Sunderland, E.M.; Ebinghaus, R. Transport of Legacy Perfluoroalkyl Substances and the Replacement Compound HFPO-DA through the Atlantic Gateway to the Arctic Ocean-Is the Arctic a Sink or a Source. Environ. Sci. Technol. 2020, 54, 9958–9967.
  3. S. Trimmel, K. Vike-Jonas, S.V. Gonzalez, T.M. Ciesielski, U. Lindstrom, B.M. Jenssen and A.G. Asimakopoulos  Rapid Determination of Per- and Polyfluoroalkyl Substances (PFAS) in Harbour Porpoise Liver Tissue by HybridSPE®–UPLC®–MS/MS Toxics 2021, 9(8), 183; https://doi.org/10.3390/toxics9080183

 

  • Sales Enquiry
  • Obter uma cotação
  • Technical Support
  • Encontre um parceiro aprovado

Sales Enquiry

At ELGA LabWater, we have exciting offers and news about our products and services that we hope you’d like to hear about. We will use your information to predict what you might be interested in. We will treat your data with respect and you can find the details in our Privacy Policy.

ELGA LabWater works with a network of Approved Partners. In order to answer your questions or enquiries, we may pass your contact details to an Approved Partner, who may contact you directly. 

I'd like to receive updates from ELGA LabWater & ELGA Approved Partners based on my details.

Obter uma cotação

At ELGA LabWater, we have exciting offers and news about our products and services that we hope you’d like to hear about. We will use your information to predict what you might be interested in. We will treat your data with respect and you can find the details in our Privacy Policy.

ELGA LabWater works with a network of Approved Partners. In order to answer your questions or enquiries, we may pass your contact details to an Approved Partner, who may contact you directly. 

I'd like to receive updates from ELGA LabWater & ELGA Approved Partners based on my details.

Technical Support

At ELGA LabWater, we have exciting offers and news about our products and services that we hope you’d like to hear about. We will use your information to predict what you might be interested in. We will treat your data with respect and you can find the details in our Privacy Policy.

ELGA LabWater works with a network of Approved Partners. In order to answer your questions or enquiries, we may pass your contact details to an Approved Partner, who may contact you directly. 

Call us

Can't find what you are looking for?

Support Number
+44 (0)20 3567 7300
United Kingdom Sales
+44 (0)1628 879 704
United States of America Sales
+1 877-315-3542
France Sales
+33 1 40 83 65 00
China Sales
+86 400-616-8882

 

Sede da ELGA LabWater

Lane End Business Park
Lane End, High Wycombe
HP14 3BY
Reino Unido
T: +44 (0) 203 567 7300
F: +44 (0) 203 567 7205

Estudos de caso

  • Abbott Diagnostics
  • DASA Medical Diagnostics
  • NeoDIN Medical Institute
  • North Staffordshire NHS Trust
  • Olsberg Vocational College

Recursos

  • Saber mais sobre água ultrapura
  • Guias e Livros Brancos
  • Tecnologias de purificação
  • Aplicações
  • Impurezas na água
  • Latest Blog
  • Water Purity - Different Types of Pure Water
  • What is Clinical Laboratory Reagent Water (CLSI)?
  • What is Total Organic Carbon (TOC)?

© VWS (UK) Ltd. negociando como ELGA LabWater.2025-Todos os direitos reservados.
ELGA é a marca global de água para laboratórios da Veolia.

  • Política de privacidade
  • Termos e condições
  • Conformidade legal global
  • Patentes
  • Trademarks
  • Impressum
  • Idioma
    • Deutsch
    • English
    • Español
    • Français
    • Italiano
    • Português
    • 日本語
    • 中文
  • Outros sítios Web da Veolia
    • Veolia
    • Veolia Foundation
    • Veolia Water Technologies
Elga Veolia
TOP

© 2017 ELGA Veolia